Michel, C., Saußele, S., Fabarius, A., Ho, A. D., & Hehlmann, R. (2019). Imatinib dose reduction in major molecular response of chronic myeloid leukemia: Results from the German Chronic Myeloid Leukemia-Study IV. Haematologica, 104(5), . https://doi.org/10.3324/haematol.2018.206797
Chicago-Zitierstil (17. Ausg.)Michel, Christian, Susanne Saußele, Alice Fabarius, Anthony Dick Ho, und Rüdiger Hehlmann. "Imatinib Dose Reduction in Major Molecular Response of Chronic Myeloid Leukemia: Results from the German Chronic Myeloid Leukemia-Study IV." Haematologica 104, no. 5 (2019). https://doi.org/10.3324/haematol.2018.206797.
MLA-Zitierstil (9. Ausg.)Michel, Christian, et al. "Imatinib Dose Reduction in Major Molecular Response of Chronic Myeloid Leukemia: Results from the German Chronic Myeloid Leukemia-Study IV." Haematologica, vol. 104, no. 5, 2019, https://doi.org/10.3324/haematol.2018.206797.